Precision Biologics Completes Patient Accrual to its Ensituximab Phase 2 Colorectal Cancer Study
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...
PRECISION BIOLOGICS, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 12, 2015 at 6:00...
DARMSTADT, Germany, Feb. 2, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, today announced an...